Fred Hutchinson Cancer Research Center
Multiomic Study Points to New Colorectal Cancer Risk Contributors
Researchers tracked down more than 100 new risk variants with a combination of genomic, transcriptomic, and methylation analyses, highlighting new and known risk pathways.
Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response
Breast and ovarian cancers with BRCA1 promoter methylation changes showed poorer chemotherapy responses than those with genetic alterations in BRCA1 or BRCA2.
CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays
Precision Assays' immuno-MRM mass spectrometry assays use antibody enrichment of protein targets followed by mass spec analysis to quantify proteins of interest.
EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center
The technologies, licensed co-exclusively, can be used to study histone post-translational modifications and chromatin-associated proteins.
Machine Learning Method Allows Highly Multiplexed Cell Surface Protein Analysis via Flow Cytometry
Premium
The method could offer a more accessible, less expensive way to measure the expression of hundreds of cell surface markers across millions of single cells.